生物协议：分散科学（DESCI）运动正在迅速改变研究

分散的科学（DESCI）运动正在迅速改变生物技术的研究，创新和资金。 BIO协议是一个由Binance Labs支持的项目，正在领导这一转变。

The decentralized science (DeSci) movement is quickly changing how research, innovation, and funding work in biotech, especially with Binance Labs-backed protocol BIO Protocol leading the way.

分散的科学（DESCI）运动正在迅速改变生物技术的研究，创新和资金工作，尤其是在Binance Labs支持的协议BIO协议中，领先的。

According to CoinGecko report, the protocol uses blockchain technology to create a decentralized space where researchers, biotech professionals, and patients can come together to fund projects, control intellectual property (IP), and collectively decide on the direction of biotechnological advancements.

根据Coingecko报告，该协议使用区块链技术创建一个分散的空间，研究人员，生物技术专业人员和患者可以聚集在一起资助项目，控制知识产权（IP），并共同决定生物技术进步的方向。

Breaking Down Traditional Research Barriers

打破传统的研究障碍

This new approach solves problems in traditional scientific research, such as limited access, stalled funding, and opaque peer-review systems. The increasing footprint of DeSci was evident in the 2,640% surge in sector growth between January and December 2024, showcasing its potential to disrupt the industry.

这种新方法解决了传统科学研究的问题，例如有限的访问，停滞的资金和不透明的同行评审系统。在2024年1月至1224年12月之间，Desci的占地面积的增加在2,640％的行业增长中显而易见，这表明了其破坏该行业的潜力。

Among the protocols spearheading this shift, BIO Protocol stands out as a major force. It's known for its community-driven initiatives like BioDAOs, tokenized governance, and liquidity tools that are fuelling sustainable biotech progress.

在带头转变的协议中，生物协议是主要力量。它以其社区驱动的计划，例如生物纪念品，令牌化治理和流动性工具而闻名，这些工具正在推动可持续生物技术的进步。

DeSci: A New Model for Research

DESCI：一种新的研究模型

Scientific research has long been controlled by centralized institutions. Universities, publishers, and funding bodies have historically held the reins of scientific endeavors. While these institutions have supported groundbreaking discoveries, they've also created barriers.

长期以来，科学研究一直由集中的机构控制。从历史上看，大学，出版商和资助机构一直持有科学努力。尽管这些机构支持了开创性的发现，但它们也创造了障碍。

This includes limited access to opportunities, slow or stalled funding, and high costs that burden researchers. DeSci presents a different model. It leverages blockchain to build an open and transparent space for research.

这包括有限的机会机会，缓慢或停滞的资金以及负担重大的研究人员。 Desci提出了不同的模型。它利用区块链建立开放透明的研究空间。

This new model encourages scientists to collaborate globally, apply for funding directly, and share their findings without restrictions.

这个新模型鼓励科学家在全球范围内进行合作，直接申请资金，并分享他们的发现无限制。

Crypto Leaders Back DeSci Vision

加密领导者回到desci愿景

Key figures in the blockchain industry, like Ethereum's Vitalik Buterin and Binance's Changpeng Zhao, have expressed optimism toward DeSci. In 2024, the growth of DeSci protocols was evident, with the top five projects, including BIO Protocol, reaching a combined market cap of over $2.3 billion in January 2025.

区块链行业的关键人物，例如以太坊的Vitalik Buterin和Binance的Changpeng Zhao，对Desci表示乐观。 2024年，DESCI协议的增长很明显，其中包括生物协议在内的前五名项目在2025年1月的综合市值超过23亿美元。

This collective footprint showcases the increasing interest in decentralized scientific collaboration and funding models.

这种集体足迹展示了对分散的科学合作和资助模型的兴趣日益增加。

BIO Protocol's Key Features

生物协议的关键特征

BIO Protocol is designed to streamline biotech research using decentralized financial models and governance. One of its main innovations is the creation of BioDAOs. These are community-driven research networks that collect funds through token sales to support biotech projects.

BIO协议旨在使用分散的财务模型和治理来简化生物技术研究。它的主要创新之一是生物的创造。这些是社区驱动的研究网络，通过令牌销售收集资金以支持生物技术项目。

IP ownership is shared among members, and the BioDAOs reinvest earnings back into research and development, forming a continuous funding cycle.

IP所有权在成员之间共享，而Biodaos将收入重新投资回到研发中，形成了一个持续的资金周期。

Rewarding Contributions and Decentralized Governance

奖励贡献和分散的治理

Another key aspect is the Bio/Acc rewards system, which incentivizes contributors, researchers, and token holders. Approximately 133 million BIO tokens, making up 4% of the total supply, have been allocated to reward active participation in the ecosystem.

另一个关键方面是生物/ACC奖励系统，它激励贡献者，研究人员和代币持有人。大约有1.33亿个生物令牌占总供应的4％，已分配以奖励积极参与生态系统。

Moreover, the protocol's curation system enables BIO token holders to vote on which projects should be funded, ensuring decentralized decision-making and fair distribution of resources.

此外，该协议的策展系统使生物令牌持有人能够对哪些项目进行投票，以确保分散的决策和资源的公平分配。

BIO Protocol also introduces Intellectual Property Tokens (IPTs), which enable fractional ownership of biotech research and innovations. These tokens grant holders governance rights and access to exclusive project updates, fostering transparency and engagement within the research community.

生物协议还引入了知识产权令牌（IPTS），该标记可以使生物技术研究和创新的分数所有权。这些令牌授予持有人的治理权利和获得独家项目更新的访问权限，从而促进了研究社区内的透明度和参与度。

Real-World Applications and Future Potential

现实世界的应用和未来潜力

One of the most pressing issues faced by the scientific community is the reproducibility of published papers. Nearly 50% of published studies fail replication tests, highlighting a critical flaw in traditional scientific reporting.

科学界面临的最紧迫的问题之一是发表论文的可重复性。近50％的已发表研究失败了复制测试，突出了传统科学报告中的一个关键缺陷。

To tackle this, BIO Protocol's architecture allows for the auditing of scientific papers using blockchain and artificial intelligence. This capability becomes particularly relevant in light of the reproducibility crisis affecting scientific papers.

为了解决这个问题，生物协议的体系结构允许使用区块链和人工智能审核科学论文。鉴于影响科学论文的可重复性危机，这种能力尤其重要。

In addition, the protocol supports public goods that traditional institutions often miss, such as scaling scientific validation efforts. Traditional funding models typically prioritize projects that promise swift financial returns.

此外，该协议支持传统机构经常错过的公共物品，例如扩展科学验证工作。传统资金模型通常会优先考虑承诺迅速财务回报的项目。

In contrast, BIO Protocol's structure, with its decentralized and community-based funding, empowers researchers to pursue groundbreaking research that benefits society. This structure encourages innovation by researchers who aren't limited by financial constraints.

相比之下，生物协议的结构凭借其分散和基于社区的资金，使研究人员有能力从事有益于社会的开创性研究。这种结构鼓励不受财务限制的研究人员的创新。

New Funding Models for Researchers

研究人员的新资金模型

Unlike traditional financial systems that demand strict investor terms, BIO Protocol's tokenized funding model offers capital without equity dilution or rigid repayment schedules.

与需要严格投资者条款的传统金融系统不同，Bio Protopity的令牌资金模型提供了资本，而无需公平稀释或严格的还款时间表。

Researchers can obtain funding through community engagement and token-based incentives, enabling them to work on high-impact projects without facing pressure to conform to predefined financial metrics.

研究人员可以通过社区参与和基于令牌的激励措施获得资金，使他们能够从事高影响力项目，而无需面对符合预定义的金融指标的压力。

Related: BIO Protocol Expands to Solana: What This Means for DeSci

相关：生物协议扩展到Solana：这对Desci意味着什么

BIO Token and Its Utility

生物令牌及其实用程序

The BIO token serves as the governance and utility token within the BIO Protocol ecosystem. Token holders participate in decision-making, vote on fund allocations, and gain access to accelerator programs that support biotech innovations. They also receive special benefits, such as whitelist opportunities in BioDAO funding rounds and potential rewards for contributions to clinical trials and research.

生物代币在生物协议生态系统中充当治理和实用程序。令牌持有人参与决策，对资金分配进行投票，并获得支持生物技术创新的加速器计划。他们还获得了特殊的好处，例如Biodao资助回合中的白名单机会，以及潜在的临床试验和研究贡献的奖励。

The total supply of BIO tokens is set at 3.32 billion and has a dynamic system that allows for adjustments through governance. At launch, 56% of the tokens were allocated for community initiatives, while the remaining 44% were distributed among early contributors,

生物代币的总供应设定为33.2亿，并且具有动态系统，可以通过治理进行调整。发布时，将56％的代币分配给社区倡议，而其余的44％则分配给早期贡献者，